In randomized trials in patients with atrial fibrillation (AF), treatment strategies that restore and maintain sinus rhythm (rhythm control) have not shown convincing advantages over those that simply ...

Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Atrial fibrillation (AF) is being increasingly understood not as an isolated electrophysiologic disorder, but as a clinical surface expression of a systemic, comorbidity-driven atrial cardiomyopathy.

DEAR DR. ROACH: A couple weeks ago, I had a sudden fast heartbeat with a very irregular and erratic pulse (approximately 150-161) for about six hours, along with a very low blood pressure, ranging ...

Men are at least 1.5 times more likely to develop atrial fibrillation. Read more at straitstimes.com. Read more at ...

Please provide your email address to receive an email when new articles are posted on . Edoxaban did not improve ischemic outcomes and raised bleeding risk in patients with atrial high-rate episodes.